Nevada Clinical Trials Report — May 2026

For Nevadans considering participation in clinical research, May 2026 presents a dynamic landscape of opportunities, with a particular emphasis on trials nearing their enrollment deadlines. Across the state, 29 clinical trials are slated to close within the next 90 days, creating a sense of urgency for those interested in contributing to medical advancements. Notably, 4 of these rapidly closing studies are actively seeking healthy volunteers, offering a chance for individuals without specific health conditions to participate before these options are no longer available.

Patients managing certain health conditions also have limited time to join research. Trials focused on neurological disorders, various cancers, and metabolic health are among those with impending deadlines for enrollment. Conditions with trials closing soon include:

• Major depressive disorder
• Advanced cancer
• Asthma
• Amyotrophic lateral sclerosis
• Anatomic stage II breast cancer AJCC v8
• Anatomic stage III breast cancer AJCC v8
• Advanced solid tumors
• Attention-deficit/hyperactivity disorder
• Behavioral variant frontotemporal dementia (bvFTD)
• Benign prostatic hyperplasia (BPH)

New Opportunities for Healthy Volunteers and Beyond

This month brings promising new avenues for participation, especially for individuals without specific medical conditions. Out of the 6 new clinical trials that opened in Nevada this May, an impressive 5 are actively recruiting healthy volunteers. This is a significant opportunity for those looking to contribute to medical science without a pre-existing diagnosis. Statewide, there are now a total of 40 trials accepting healthy volunteers, providing numerous options to get involved.

The new trials are exploring a range of conditions and interventions, reflecting diverse research interests. This month's new studies are targeting:

• Cognitive decline
• Cognitive function
• Healthy adult participants
• Heart failure
• Hs-CRP (high-sensitivity C-reactive protein)
• Low libido
• Memory
• Obesity
• Obesity (BMI > 30)
• Overweight (BMI > 25)

The types of interventions being studied are varied, with dietary supplements leading the way, accounting for 3 of the new trials. Drug trials represent 2 of the new studies, with 1 additional trial categorized as 'OTHER'.

A Major Phase 3 Trial from Novo Nordisk

Among the new studies, one notable Phase 3 trial stands out for its scope and sponsor. Novo Nordisk A/S is sponsoring NCT07567001, titled "A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity." This substantial global trial aims to enroll 5,610 participants. Its purpose is to evaluate the safety and effect of NNC0487-0111 in individuals with Heart Failure with preserved Ejection Fraction (HFpEF) or Heart Failure with mildly reduced Ejection Fraction (HFmrEF) who also have excess body weight.

Other sponsors contributing to Nevada's research landscape this month include Bio Nature Health, which is sponsoring 3 of the new trials, Corium Innovations, Inc., and the Midwest Center for Metabolic and Cardiovascular Research. The majority of these new initiatives are industry-sponsored, accounting for 5 of the 6 new trials.

Nevada's Research Footprint: A Look at Geographic Distribution

Nevada currently hosts a robust research environment with 542 clinical trials actively recruiting across 14 cities and 398 research sites. This broad distribution ensures that opportunities are available in various communities throughout the state.

This month, all 6 of the new trials opened in Las Vegas, indicating a concentration of new research initiatives in the state's largest metropolitan area. While new opportunities are currently focused in Las Vegas, the overall number of recruiting trials remains strong across the state, offering diverse options for participation.

Looking at the trend over the past six months, May's opening of 6 new trials shows an increase compared to April 2026, which saw only 3 new trials. This month's activity is on par with December 2025 and March 2026, which saw 32 and 12 new trials respectively, and higher than January and February 2026, both with 10 new trials. This fluctuation highlights the dynamic nature of clinical research, with new opportunities emerging consistently.

Who Can Participate? Eligibility and Demographics

Clinical trials in Nevada are designed to include a diverse range of participants. Of the 6 new trials launched this month, 6 include older adults, ensuring that senior populations have ample opportunities to contribute to medical science. There is also 1 new trial specifically for male participants. No new trials this month are exclusively for females or include children, based on the current data.

For those interested in exploring clinical trials, especially the ones closing soon or the new opportunities for healthy volunteers, acting promptly is key. The contributions of volunteers are essential for advancing medical knowledge and developing new treatments.

As we move further into May, the focus will remain on the ongoing enrollment in these significant studies, while researchers continue to prepare for future waves of innovative trials addressing a broad spectrum of health challenges across Nevada.